Durham, North Carolina
United States
14
2025-10-09
The entities that hold a legal rights for patent applications filed by inventor Beard Clayton:
Clayton Beard from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:
GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED TRANSFERRIN GENE
#2 | 2025-04-10GENE THERAPY FOR GENETIC HEARING LOSS
#3 | 2025-01-23ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#4 | 2025-01-02GENE THERAPY FOR GALACTOSEMIA
#5 | 2024-06-13GENE THERAPIES FOR 21-HYDROXYLASE DEFICIENCY
#6 | 2022-07-21NUCLEIC ACID MOLECULES ENCODING AN ENGINEERED ANTIGEN RECEPTOR AND AN INHIBITORY NUCLEIC ACID MOLECULE AND METHODS OF USE THEREOF
#7 | 2022-06-23ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A
#8 | 2022-04-21GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED TRANSFERRIN GENE
#9 | 2021-09-09GENETICALLY-MODIFIED T CELLS COMPRISING A MODIFIED INTRON IN THE T CELL RECEPTOR ALPHA GENE
#10 | 2020-10-29NUCLEIC ACID MOLECULES ENCODING AN ENGINEERED ANTIGEN RECEPTOR AND AN INHIBITORY NUCLEIC ACID MOLECULE AND METHODS OF USE THEREOF
#11 | 2020-09-24ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#12 | 2020-04-23Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
#13 | 2020-02-27Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
#14 | 2019-05-16Engineered nucleases useful for treatment of hemophilia A
2499585 ⎘